Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷或者烷化剂的治疗应该每年接受胞计数检查,监测骨髓发育不或继发性白病的发生迹象。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷或者烷化剂的治疗应该每年接受胞计数检查,监测骨髓发育不或继发性白病的发生迹象。
声:例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。